Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Apr 27, 2024; 16(4): 1109-1120
Published online Apr 27, 2024. doi: 10.4240/wjgs.v16.i4.1109
Table 1 Baseline data before and after propensity score matching in the two groups of patients, n (%)
VariablesBefore PSM
After PSM
DTR (n = 35)RY (n = 42)P valueDTR (n = 31)RY (n = 31)P value
Age (yr)0.5821
    ≤ 6020 (57.1)19 (45.2)16 (51.6)16 (51.6)
    > 6015 (42.9)23 (54.8)15 (48.4)15 (48.4)
Sex0.9891
    Female8 (22.9)9 (21.4)7 (22.6)7 (22.6)
    Male27 (77.1)33 (78.6)24 (77.4)24 (77.4)
BMI0.9320.594
    18.4-24.216 (45.7)21 (50.0)16 (51.6)12 (38.7)
    24.3-34.6719 (54.3)21 (50.0)15 (48.4)19 (61.3)
Tumor location10.968
    Upper20 (57.1)24 (57.1)18 (58.1)17 (54.8)
    Middle/lower15 (42.9)18 (42.9)13 (41.9)14 (45.2)
TNM stage0.4810.878
    I/II16 (45.7)25 (59.5)16 (51.6)18 (58.1)
    III19 (54.3)17 (40.5)15 (48.4)13 (41.9)
Longest tumor diameter (cm)0.7070.968
    0.8-3.915 (42.9)22 (52.4)15 (48.4)16 (51.6)
    4.0-14.020 (57.1)20 (47.6)16 (51.6)15 (48.4)